SHR-7280
- Generic Name
- SHR-7280
A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers
- First Posted Date
- 2024-05-10
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT06408948
- Locations
- 🇨🇳
The First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu, China
A Phase 1 Dose Escalation and Expansion Study Of SHR7280 In Subjects With Hormone Sensitive Prostate Cancer
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT04995042
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
The PK/PD Study of SHR7280 Tablets in Healthy Subjects.
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 118
- Registration Number
- NCT04554043
- Locations
- 🇨🇳
Affiliated Hospital of Qingdao University, Qingdao, Shan Dong, China
The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 179
- Registration Number
- NCT04417972
- Locations
- 🇨🇳
Peking University Third Hospital, Peking, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath